-
First trimester screening for gestational diabetes mellitus by maternal factors and markers of inflammation.
Syngelaki A, Visser GH, Krithinakis K, Wright A, Nicolaides KH.
Metabolism 2016;65:131-7. pdf -
Longitudinal changes in maternal soluble endoglin and angiopoietin-2 in women at risk of preeclampsia.
Khalil A, Maiz N, Garcia-Mandujano R, ElKhouli M, Nicolaides KH.
Ultrasound Obstet Gynecol 2014;44:402-10. pdf -
Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30-33 weeks in the prediction of preeclampsia.
Mosimann B, Wagner M, Birdir C, Poon LC, Nicolaides KH.
J Matern Fetal Neonatal Med 2013;26:763-7. -
First-trimester maternal serum tumor necrosis factor receptor-1 and pre-eclampsia.
Leal AM, Poon LC, Frisova V, Veduta A, Nicolaides KH.
Ultrasound Obstet Gynecol 2009;33:135-41. -
Maternal serum angiopoietin-2 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R, Casagrandi D, Skyfta E, Ahmed AA, Nicolaides KH.
Prenat Diagn 2009;29:847-51. -
Sonographic measurement of cervical length and fetal fibronectin testing in threatened preterm labor.
Tsoi E, Akmal S, Geerts L, Jeffery B, Nicolaides KH.
Ultrasound Obstet Gynecol 2006;27:368-72. -
Cervicovaginal fibronectin and cervical length at 23 weeks of gestation: relative risk of early preterm delivery.
Heath VC, Daskalakis G, Zagaliki A, Carvalho M, Nicolaides KH.
BJOG 2000;107:1276-81.